Spark Investment Management LLC Lipocine Inc. Transaction History

Spark Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$1.79 - $3.33 $31,683 - $58,941	-17,700 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$1.43 - $2.32 $47,766 - $77,494	-33,403 Reduced 65.36%	17,700 $34,000
Q1 2019 May 07, 2019	BUY	$1.46 - $2.33 $74,610 - $119,069	51,103 New	51,103 $118,000
Q1 2018 May 10, 2018	SELL	$1.18 - $3.46 $14,868 - $43,596	-12,600 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$3.36 - $4.35 $42,336 - $54,809	12,600	12,600 $43,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $435M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.